MTOR and cancer: Regardless, both studies support the notion that the accumulation of excess cholesterol results in activation of the PI3K-AKT-mTOR signaling pathway, suggesting that reducing intracellular cholesterol levels could be an attractive therapeutic target in certain human cancers.